Evofem Biosciences, Inc. (NASDAQ:EVFM – Get Free Report)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 720,767 shares changing hands.
Evofem Biosciences Price Performance
The stock has a market cap of $1.02 million, a PE ratio of -0.01 and a beta of -0.87. The stock has a 50-day simple moving average of $0.01 and a 200-day simple moving average of $0.01.
Evofem Biosciences Company Profile
Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Featured Articles
- Five stocks we like better than Evofem Biosciences
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Best Stocks Under $10.00
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Insider Trading – What You Need to Know
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
